The multidisciplinary approach to the Marfan patient

Israel Medical Association Journal

Volumn 10, Issue 3, 2008, Pages 171-174

  Raanani, Ehud ^a,b   Ghosh, Probal ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Beta blockade; Ghent criteria; Marfan syndrome; MASS phenotype (mitral, aortic, skin, and skeletal manifestations); Multidisciplinary approach; Valve sparing surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRILLIN 1; LOW MOLECULAR WEIGHT HEPARIN; PERINDOPRIL; PROPANOL; VERAPAMIL; WARFARIN;

ANEURYSM; AORTA ANEURYSM; AORTIC ROOT SURGERY; ARTERY DISEASE; ARTERY DISSECTION; ARTICLE; CARDIOVASCULAR RISK; CATARACT; CLEFT PALATE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DRUG EFFICACY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GLAUCOMA; HOMOCYSTINURIA; HUMAN; HYPERTELORISM; MARFAN SYNDROME; PREGNANCY; PRENATAL CARE; PREVALENCE; RETINA DETACHMENT; RISK ASSESSMENT; RISK REDUCTION; SUDDEN DEATH;

AORTIC ANEURYSM; DIAGNOSIS, DIFFERENTIAL; HUMANS; MARFAN SYNDROME;

EID: 43249111555     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Marfan AB. Un cas de deformation congenitale des quarte members plus prononcee aux extremites caracterisee par l'allongement des os avec un certain degre d'amincissement. Bull Mem Soc Med Hop Paris 1886;13:220-6.
2. Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972;286:804-8.
3. Silverman DI, Burton KI, Gray J, et al. Life expectancy in the Marfan syndrbme. Am J Cardiol 1995;75:157-60.
4. Frydman M. The Marfan syndrome. IMAJ 2008;10:175-8.
5. Motro M, Fisman EZ, Tenenbaum A. Cardiovascular management of Marfan syndrome. IMAJ 2008;10:182-5.
6. Nahum Y, Spierer A. Ocular features of Marian syndrome: diagnosis and managment. IMAJ 2008;10:179-81.
7. Avivi E, Arzi H, Paz L, Caspi I, Chechik A. Skeletal manifestations of Marfan syndrome. IMAJ 2008;10:186-8.
8. Sheick-Yousif B, Sheinfield A, Tager S, Ghosh P, et al. Aortic root surgery in Marfan syndrome. IMAJ 2008;10:189-93.
9. Gray JR, Bridges AB, Faed MJ, et al. Ascertainment and severity of Marfan syndrome in a Scottish population. J Med Genet 1994; 31:51-4.
10. Beighton P, de Paepe A, Danks D, et al. International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986. Am J Med Genet 1988;29:581-94.
11. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62:417-26.
12. Montgomery RA, Geraghty MT, Bull E, et al. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet 1998;63:1703-11.
13. Tsipouras P, Del Mastro R, Sarfarazi M, et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractutal arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med 1992;326:905-9.
14. Gale AN, McKusick VA, Hutchins GM, Gott VL. Familial congenital bicuspid aortic valve: secondary calcific aortic stenosis and aortic aneurysm. Chest 1977;72:668-70.
15. Lawson ML, Mellins RB, Tabangin M, et al. Impact of pectus excavatum on pulmonary function before and after repair with the Nuss procedure. J Pediatr Surg 2005;40:174-80; discussion.180.
16. Haller J, Colombani PM, Humphries CT, Azizkhan RG, Loughlin GM. Chest wall constriction after the extensive and too early operations for pectus excavatum. Anns Thorac Surg 1996;61:1618-25.
17. Salim MA, Alpert BS, Ward JC, Pyeritz RE. Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome. Am J Cardiol 1994;74:629-33.
18. Rossi-Foulkes R, Roman MJ, Rosen SE, et al. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size In the Marfan syndrome. Am J Cardiol 1999;83: 1364-8.
19. Shores J, Berger KR, Murphy EA, Pyerltz RE. Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. N Engl J Med 1994;330:1335-41.
20. Ahimastos AA, Aggarwal A, D'Orsa KM, et al. Effect of perindopril on large artery stiffness and aortic root diameter in patients with Marfan syndrome: a randomized controlled trial. JAMA 2007; 298:1539-47.
21. Bentall H, De Bono A. A technique for complete replacement of the ascending aorta. Thorax 1968;23:338-9.
22. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan's syndrome. N Engl J Med 1999;340: 1307-13.
23. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of the ascending aorta. J Thorac Cardiovasc Surg 1992;103:617-21; discussion 622.
24. de Oliveira NC, David TE, Ivanov J, et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 2003;125:789-96.
25. Birks EJ, Webb C, Child A, Radley-Smith R, Yacoub MH. Early and long-term results of a valve-sparing operation for Marfan syndrome. Circulation 1999;100:1129-35.
26. Meijboorn LJ, Vos FE, Timmermans J, et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J 2005;26:914-20.
27. Ageno W, Crotti S, Turpie AG. The safety of antithrombotic therapy during pregnancy. Expert Opin Drug Saf 2004;3:113-18.